|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.98 USD | -6.17% |
|
-9.42% | +35.83% |
| 05-08 | Neurogene Insider Sold Shares Worth $300,043, According to a Recent SEC Filing | MT |
| 05-06 | Neurogene announces inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.17% | -9.42% | +0.47% | +62.58% | +35.83% | +55.53% | - | - | - | 442M | |
| +3.64% | +1.49% | -7.76% | -9.85% | -9.78% | -15.50% | -16.06% | -13.14% | +186.93% | 41.61B | |
| -0.06% | -5.68% | -9.50% | -18.37% | -3.53% | +28.33% | +28.14% | -13.28% | +973.20% | 32.58B | |
| -0.89% | +0.15% | -2.87% | +44.67% | +81.26% | +265.12% | +468.83% | +337.35% | - | 30.69B | |
| +2.18% | -0.43% | -2.07% | +1.02% | -23.34% | +21.00% | -11.58% | -25.05% | +162.43% | 28.84B | |
| -2.97% | -4.23% | -11.71% | -23.03% | +1.22% | +23.72% | +16.24% | -21.98% | +175.27% | 25.65B | |
| -1.19% | -0.43% | - | - | - | - | - | - | - | 14.76B | |
| -2.76% | +1.68% | -3.07% | -12.88% | +32.33% | +168.71% | +4,393.86% | - | - | 13.74B | |
| -2.30% | -3.79% | -4.21% | -11.80% | -8.33% | +116.09% | +97.98% | +96.69% | +116.54% | 11.98B | |
| +2.10% | +3.68% | -11.73% | -8.96% | -1.63% | +9.84% | +1.49% | -26.54% | +90.62% | 12.3B | |
| +1.30% | +0.81% | -19.20% | -5.72% | -25.10% | +37.63% | +101.14% | +160.28% | - | 12.01B | |
| -6.44% | -3.40% | -6.41% | -2.55% | +8.75% | +765.83% | +2,036.87% | +4.19% | - | 8.94B | |
| +2.46% | -5.54% | -2.63% | -10.95% | -18.65% | +1,748.11% | +432.92% | +364.22% | +873.66% | 8.87B | |
| -2.23% | -4.35% | -4.93% | +17.91% | -37.56% | -13.56% | -45.35% | -48.83% | +78.12% | 8.69B | |
| -0.71% | -9.99% | -21.93% | -22.33% | -26.13% | -33.39% | - | - | - | 7.83B | |
| -0.61% | -11.00% | -18.46% | -5.11% | -24.84% | +6.36% | -24.76% | -53.10% | +78.66% | 7.22B | |
| +2.06% | +1.30% | +12.76% | +18.31% | +30.55% | +49.38% | -17.47% | -16.72% | +458.57% | 7.28B | |
| +2.43% | +3.52% | -18.09% | -31.10% | -28.64% | -24.76% | -32.63% | -35.24% | +35.67% | 6.99B | |
| +2.61% | -6.31% | -24.99% | -25.11% | -24.45% | -9.60% | -46.64% | -55.57% | +73.20% | 6.96B | |
| -3.09% | -5.27% | -9.17% | -6.39% | +2.39% | +163.37% | +168.70% | +94.98% | - | 6.55B | |
| Average | -0.53% | -3.75% | -8.71% | -2.61% | -2.09% | +176.96% | +444.22% | +46.77% | +275.24% | 14.7B | |
| Weighted average by Cap. | +0.10% | -2.86% | -8.04% | -4.10% | +1.57% | +133.02% | +366.91% | +51.22% | +323.02% |
- Stock Market
- Equities
- NGNE Stock
- Sector Neurogene Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition